3Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical application [ J ]. Am J Respir Crit Care Med,2011,184(5) :602-615.
4Berry MA, Shaw DE, Green RI-I, et al. The use of exhaled nitric oxide concentration to identify eosinophilic airwayinflammation: an observational study in adults with asthma [J ]. Clin Exp Allergy,2005,35(9) : 1175-1179.
5Barreto M, Villa MP, Monti F, et al. Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms [ J ]. Pediatr Allergy Immunol, 2005,16 ( 1 ) : 52-58.
6Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial [J]. Am J Respir Crit Care Med, 2007,176(3) :231-237.
7Porsbjerg C, Lund TK, Pedersen L, et al. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO [J]. J Asthma,2009,46(6): 606-612.
8Prez-de-Llan LA, Carballada F, Castro Aii6n O, et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma [J]. Eur Respir J,2010,35 (6): 1221-1227.
9Olin AC, Bake B, Torrn K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never- smokers [J]. Chest,2007,131(6) : 1852-1856.
10Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults [J]. Am J Respir Crit Care Med,2007, 176(3) :238-242,.
